Photo from wikipedia
Hematopoietic stem cell transplantation (HSCT) recipients require hepatitis B (HBV) revaccination. Hepatitis B surface antibody (anti‐HBs) seroconversion rates after revaccination range from 64% to 79% in these patients. The seroconversion… Click to show full abstract
Hematopoietic stem cell transplantation (HSCT) recipients require hepatitis B (HBV) revaccination. Hepatitis B surface antibody (anti‐HBs) seroconversion rates after revaccination range from 64% to 79% in these patients. The seroconversion rate and factors associated with non‐seroconversion have not been clearly elucidated in pediatric and young adult recipients after HSCT.
Keywords:
young adult;
pediatric young;
cell transplantation;
stem cell;
transplantation;
hematopoietic stem
Journal Title: Clinical Transplantation
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical Transplantation
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!